This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, J. Articles by Mike Makrigiorgos, G. Search for Related Content PubMed PubMed Citation Articles by Li, J. Articles by Mike Makrigiorgos, G.

JMD 2006, Vol. 8, No. 1
Copyright © 2006 American Society for Investigative Pathology & Association for Molecular Pathology

Technical Advances

Whole Genome Amplification of Plasma-Circulating DNA Enables Expanded Screening for Allelic Imbalance in Plasma

Jin Li^*, Lyndsay Harris, Harvey Mamon^*, Matthew H. Kulke, Wei-Hua Liu^*, Penny Zhu^* and G. Mike Makrigiorgos^*

From the Departments of Radiation Oncology * and Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Abstract

Apoptotic and necrotic tumor cells release DNA into plasma, providing an accessible tumor biomarker. Tumor-released plasma-circulating DNA can be screened for tumor-specific genetic changes, including mutation, methylation, or allelic imbalance. However, technical problems relating to the quantity and quality of DNA collected from plasma hinder downstream genetic screening and reduce biomarker detection sensitivity. Here, we present a new methodology, blunt-end ligation-mediated whole genome amplification (BL-WGA), that efficiently amplifies small apoptotic fragments (<200 bp) as well as intermediate and large necrotic fragments (>5 kb) and enables reliable high-throughput analysis of plasma-circulating DNA. In a single-tube reaction, purified double-stranded DNA was blunted with T4 DNA polymerase, self-ligated or cross-ligated with T4 DNA ligase and amplified via random primer-initiated multiple displacement amplification. Using plasma DNA from breast cancer patients and normal controls, we demonstrate that BL-WGA amplified the plasma-circulating genome by 1000-fold. Of 25 informative polymorphic sites screened via polymerase chain reaction-denaturating high-performance liquid chromatography, 24 (95%) were correctly determined by BL-WGA to be allelic retention or imbalance compared to 44% by multiple displacement amplification. By enabling target magnification and application of high-throughput genome analysis, BL-WGA improves sensitivity for detection of circulating tumor-specific biomarkers from bodily fluids or for recovery of nucleic acids from suboptimally stored specimens.

This article has been cited by other articles:

				D. T. Croft Jr, R. M. Jordan, H. L. Patney, C. D. Shriver, M. N. Vernalis, T. J. Orchard, and D. L. Ellsworth Performance of Whole-Genome Amplified DNA Isolated from Serum and Plasma on High-Density Single Nucleotide Polymorphism Arrays J. Mol. Diagn., May 1, 2008; 10(3): 249 - 257. [Abstract] [Full Text] [PDF]

				G. Amicarelli, E. Shehi, G. M. Makrigiorgos, and D. Adlerstein FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations Nucleic Acids Res., October 11, 2007; (2007) gkm809v1. [Abstract] [Full Text] [PDF]

				F. Wang, L. Wang, C. Briggs, E. Sicinska, S. M. Gaston, H. Mamon, M. H. Kulke, R. Zamponi, M. Loda, E. Maher, et al. DNA Degradation Test Predicts Success in Whole-Genome Amplification from Diverse Clinical Samples J. Mol. Diagn., September 1, 2007; 9(4): 441 - 451. [Abstract] [Full Text] [PDF]

				A. Sahota, A. I. Brooks, and J. A. Tischfield Preparing DNA from Mammalian Sources for Genotyping CSH Protocols, July 1, 2007; 2007(16): pdb.top19 - pdb.top19. [Abstract] [Full Text]

				J. Li, F. Wang, H. Mamon, M. H. Kulke, L. Harris, E. Maher, L. Wang, and G. M. Makrigiorgos Antiprimer Quenching-Based Real-Time PCR and Its Application to the Analysis of Clinical Cancer Samples Clin. Chem., April 1, 2006; 52(4): 624 - 633. [Abstract] [Full Text] [PDF]